New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics A Review

with Sonya Das, Raphael Rousseau, Peter C. Adamson, JAMA Oncology

View abstract

Patient-centered clinical trials

with Shomesh E. Chaudhuri,  Martin P. Ho, Telba Irony, and Murray Sheldon, Drug Discovery Today Volume 23, Issue 2, February 2018, Pages 395-401

View abstract

Estimation of clinical trial success rates and related parameters

with Chi Heem Wong, Kien Wei Siah, Biostatistics (2018) 00, 00, pp. 1–14

View abstract

What Post-Crisis Changes Does the Economics Discipline Need?: Beware of Theory Envy!

What’s the Use of Economics?: Teaching the Dismal Science After the Crisis, London Publishing Partnership.

View abstract

The FTSE StableRisk Indices

with Jeremiah Chafkin and Robert Sinnott, Journal of Index Investing 2(2011), 12–35.

View abstract

Managing real-time risks and returns: The Thomson Reuters NewsScope Event Indices

with Alexander D. Healy, The Handbook of News Analytics in Finance

View abstract

Just how good an investment is the biopharmaceutical sector?

with Richard T Thakor, Nicholas Anaya, Yuwei Zhang, Christian Vilanilam, Kien Wei Siah, Chi Heem Wong, Nature Biotechnology

View abstract

Do Stock Prices Follow Random Walks?

with A. Craig MacKinlay, Financial Times

Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program

with Sonya Das, Contemporary Clinical Trials 62 (2017) 168–174

View abstract

The Growth of Relative Wealth and the Kelly Criterion

with H. Allen Orr and Ruixun Zhang, Journal of Bioeconomics April 2018, Volume 20, Issue 1, pp 49–67

View abstract

Follow me on © 2018 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design